Current available jobs worldwide.
Join our team
News and Features
9-29-2014: U.S. FDA approves dual-chamber syringe for ABILIFY MAINTENA® (aripiprazole) extended-release injectable suspension for the treatment of schizophrenia
9-24-2014: US FDA accepts Otsuka and Lundbeck's filing for review of brexpiprazole for the treatment of schizophrenia and as adjunctive therapy for the treatment of major depression
Progress in Mind
Lundbeck is dedicated to raising awareness and research into brain diseases.